#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Iron overload Leukocyte adhesion deficiency Meningitis meningococcal Inflammatory myofibroblastic tumour Osteosarcoma metastatic Familial hypertriglyceridaemia Homocystinuria Idiopathic pulmonary fibrosis Bile acid synthesis disorder Retinopathy of prematurity Endometrial cancer recurrent Synovial sarcoma recurrent Juvenile psoriatic arthritis Vulval cancer Ependymoma More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Treatment Rhabdomyosarcoma recurrent – Trials in Disease Glycogen storage disease type I Hairy cell leukaemia recurrent – Basic Information Netherton’s syndrome – Life with Disease Retinoblastoma – Treatment Acquired haemophilia – Trials in Disease Epidermolysis bullosa – Life with Disease Turner’s syndrome – Basic Information Turner’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bevacizumab Pritelivir Leuprorelin Acetate Idelalisib Diclofenac Sodium Ranitidine Dirocaftor L-METHIONINE Tasquinimod Filgrastim FRUQUINTINIB Macrogol 4000 Selumetinib Pemetrexed Diacid Monohydrate Tipapkinogene Sovacivec Rocatinlimab Ganaxolone GSKVX000000030918 Zongertinib TALADEGIB More therapies…

    Learn about Your Condition

    Biliary cancer metastatic Vomiting Gastrointestinal carcinoma Apheresis Primary hyperoxaluria Pterygium Dementia Alzheimer's type Colon cancer stage IV Vestibular disorder BK virus infection Eosinophilic oesophagitis Myotonic dystrophy Malignant mast cell neoplasm VEXAS syndrome Aphthous ulcer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Long-Term Safety of Belimumab for Adults with Systemic Sclerosis-Related Lung Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Belimumab
    Belgium Denmark Finland France Germany Greece +2

  • Study on the Effectiveness of Early PSMA-PET Scans with Gozetotide in Patients with Metastatic Renal Cancer Undergoing Standard Immunotherapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Gozetotide
    Belgium

  • Study of Arfolitixorin, 5-Fluorouracil, Oxaliplatin, and Bevacizumab for Patients with Metastatic Colorectal Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • ARFOLITIXORIN
    • Calcium Folinate
    Germany

  • Study on the Effects of Oral Lidocaine (ORE-001) on Food Intake in Underweight Elderly Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Underweight
    Investigated Drugs:
    • Lidocaine Hydrochloride Monohydrate
    The Netherlands

  • Study on Bumetanide for Improving Cognitive Function in Children and Adolescents with Down Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    • Trisomy 21
    Investigated Drugs:
    • BUMETANIDE
    Italy

  • Study on the Effects of Tumor Removal in Patients with Metastatic Kidney Cancer Treated with Nivolumab and Ipilimumab Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastatic renal cell carcinoma
    Investigated Drugs:
    • Axitinib
    • Ipilimumab
    • Cabozantinib
    Italy
Previous Page
1 … 277 278 279 280 281 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!